Consolidated Statements of Income (Loss) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 25, 2022	Sep. 26, 2021	Sep. 25, 2022	Sep. 26, 2021
Consolidated Statements of Income (Loss)
Revenues	$ 120,512,900	$ 108,536,200	$ 232,674,100	$ 213,492,300
Cost of goods sold	96,328,000	88,740,500	186,125,800	174,010,300
Gross profit	24,184,900	19,795,700	46,548,300	39,482,000
Selling, general and administrative expenses	22,693,100	20,988,000	45,304,500	42,634,900
Operating income (loss)	1,491,800	(1,192,300)	1,243,800	(3,152,900)
Interest expense, net	383,400	158,700	642,800	372,400
Income (loss) from continuing operations before income taxes	1,108,400	(1,351,000)	601,000	(3,525,300)
Provision for (benefit from) income taxes	(62,400)	(75,700)	(52,400)	(37,200)
Net income (loss) from continuing operations	1,170,800	(1,275,300)	653,400	(3,488,100)
Income (loss) from discontinued operations, net of taxes	(29,900)	448,600	212,400	944,100
Net income (loss)	$ 1,140,900	$ (826,700)	$ 865,800	$ (2,544,000)
Basic income (loss) per share
Continuing operations (in dollars per share)	$ 0.13	$ (0.14)	$ 0.07	$ (0.39)
Discontinued operations (in dollars per share)	0.00	0.05	0.02	0.11
Consolidated operations (in dollars per share)	0.12	(0.09)	0.10	(0.29)
Diluted income (loss) income per share
Continuing operations (in dollars per share)	0.13	(0.14)	0.07	(0.39)
Discontinued operations (in dollars per share)	0.00	0.05	0.02	0.11
Consolidated operations (in dollars per share)	$ 0.12	$ (0.09)	$ 0.09	$ (0.29)
Basic weighted-average common shares outstanding (in shares)	9,152,476	8,910,365	9,108,586	8,889,478
Effect of dilutive options and other equity instruments (in shares)	26,763		64,832
Diluted weighted-average common shares outstanding (in shares)	9,179,239	8,910,365	9,173,418	8,889,478